TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Is it Time to Buy the TSX’s 3 Worst-Performing Stocks This Year?
Cannabis Stocks
Is Canopy Growth Stock Worth a Buy in September?
Cannabis Stocks
If You’d Invested $10,000 in Canopy Growth Stock When Cannabis Became Legal, Here’s What You’d Be Left with Today
Cannabis Stocks
Never Liked Canopy Growth Stock? Time for a Fresh Look
Cannabis Stocks
Are Cannabis Stocks a Good Buy in August 2023?
Investing
3 Stocks With Good Odds of Doubling Your Money in 2023
Cannabis Stocks
2 Cheap Cannabis Stocks Worth Keeping a Close Eye On
Cannabis Stocks
Canopy Growth Stock Just Hit 52-Week Lows: Bargain or Beware?
Cannabis Stocks
Canopy Growth – Will it Ever Recover?
Cannabis Stocks
Is it Officially Game Over for Canopy Growth Stock?